Biospecimen Core
$47,678P50FY2009CANIH
University Of Tx Md Anderson Can Ctr, Houston TX
Investigators
Linked publications & trials
Paper 34426436Paper 33735664Paper 33145806Paper 30782609Paper 30250823Paper 29674644Paper 29604930Paper 29490944Paper 29255458Paper 29137349Paper 29118007Paper 28949959Paper 28900149Paper 28802908Paper 28801451Paper 28745330Paper 28737232Paper 28627414Paper 28388555Paper 28281555Paper 28242522Paper 28143883Paper 28100459Paper 27941215Paper 27849617Paper 27773462Paper 27760757Paper 27568520Paper 27482888Paper 27389057Paper 27363492Paper 27300436Paper 27163741Paper 27105079Paper 27060228Paper 26927665Paper 26885608Paper 26884599Paper 26878872Paper 26784544Paper 26719098Paper 26699946Paper 26655726Paper 26652033Paper 26573234Paper 26541272Paper 26432723Paper 26421453Paper 26416427Paper 26375587Paper 26358140Paper 26340096Paper 26330164Paper 26324762Paper 26308769Paper 26118455Paper 26111978Paper 26104577Paper 26101854Paper 26048327Paper 25818067Paper 25760242Paper 25711538Paper 25614448Paper 25613730Paper 25613729Paper 25605746Paper 25439689Paper 25409149Paper 25406351Paper 25124685Paper 24859530Paper 24852241Paper 24771328Paper 24766216Paper 24747434Paper 24648050Paper 24611650Paper 24599548Paper 24583797Paper 24336156Paper 24290221Paper 24154679Paper 24097867Paper 24071012Paper 24037725Paper 23982177Paper 23773454Paper 23686488Paper 23676502Paper 23649469Paper 23611563Paper 23565503Paper 23564911Paper 23515929Paper 23508008Paper 23469246Paper 23449635Paper 23407473Paper 23370596
Abstract
This Core interacts with all projects of the Lymphoma SPORE, and will be ufilized by clinical and basic invesfigafions to assist them in data acquisition and analysis aiming at improving the cure rate of lymphoma by introducing new therapies.
View original record on NIH RePORTER →